BBIO vs ALB

Comparison between BridgeBio Pharma Inc (BBIO, Company) and Albemarle Corp (ALB, Company).

BBIO is from the Healthcare sector, while ALB is from the Basic Materials sector.

5-Year PerformanceBBIO has outperformed ALB, delivering a return of +5.8% compared to -6.3%

BBIO vs ALB - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	BBIO(COMPANY)	ALB(COMPANY)
Market Cap	$15B	$15B
Max Drawdown	92.80%	84.40%
Sharpe Ratio	1.46	1.20
5Y Beta	1.04	1.61
Industry	Biotechnology	Specialty Chemicals
P/E Ratio	-20.77	-65.26
Forward P/E	N/A	13.53
PEG Ratio	-3.70	0.79
Dividend Yield	N/A	1.25%
5Y Dividends CAGR	N/A	5.49%
5Y EPS CAGR	-3.14%	N/A
Debt to Equity	-116.44%	19.10%
Free Cash Flow Yield	-2.90%	3.78%
P/S Ratio	26.31	2.78
P/B Ratio	123.68	2.10

Market Cap

Winner

BBIO

$15B

ALB

$15B

Max Drawdown

BBIO

92.80%

Winner

ALB

84.40%

Sharpe Ratio

Winner

BBIO

1.46

ALB

1.20

5Y Beta

Winner

BBIO

1.04

ALB

1.61

Industry

BBIO

Biotechnology

ALB

Specialty Chemicals

P/E Ratio

BBIO

-20.77

Winner

ALB

-65.26

Forward P/E

BBIO

N/A

ALB

13.53

PEG Ratio

Winner

BBIO

-3.70

ALB

0.79

Dividend Yield

BBIO

N/A

ALB

1.25%

5Y Dividends CAGR

BBIO

N/A

ALB

5.49%

5Y EPS CAGR

BBIO

-3.14%

ALB

N/A

Debt to Equity

Winner

BBIO

-116.44%

ALB

19.10%

Free Cash Flow Yield

BBIO

-2.90%

Winner

ALB

3.78%

P/S Ratio

BBIO

26.31

Winner

ALB

2.78

P/B Ratio

BBIO

123.68

Winner

ALB

2.10

BBIO vs ALB - Historical Returns

Returns include dividend reinvestment.

Period	BBIO	ALB
1 month	+24.37%	-26.15%
3 months	+6.69%	-31.97%
6 months	+5.02%	-28.50%
1 year	+74.21%	+77.45%
5 years(CAGR)	+5.78%	-6.29%
10 years(CAGR)	N/A	+5.34%
Max(CAGR)	+16.96%	+11.89%

Winner

BBIO

+24.37%

ALB

-26.15%

Winner

BBIO

+6.69%

ALB

-31.97%

Winner

BBIO

+5.02%

ALB

-28.50%

BBIO

+74.21%

Winner

ALB

+77.45%

5Y(CAGR)

Winner

BBIO

+5.78%

ALB

-6.29%

10Y(CAGR)

BBIO

N/A

ALB

+5.34%

Max(CAGR)

Winner

BBIO

+16.96%

ALB

+11.89%

BBIO vs ALB - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

Year	BBIO	ALB
2026	+6.19%	-12.13%
2025	+171.24%	+69.37%
2024	-32.16%	-40.46%
2023	+463.04%	-32.07%
2022	-55.59%	-7.76%
2021	-73.79%	+54.41%
2020	+114.06%	+106.78%
2019	+27.22%	-4.60%
2018	N/A	-40.58%
2017	N/A	+46.84%
2016	N/A	+57.51%
2015	N/A	-4.95%
2014	N/A	-3.13%
2013	N/A	+0.06%
2012	N/A	+19.42%
2011	N/A	-6.62%
2010	N/A	+48.29%
2009	N/A	+60.40%
2008	N/A	-44.46%
2007	N/A	+15.81%
2006	N/A	+77.63%
2005	N/A	+2.50%
2004	N/A	+30.33%
2003	N/A	+7.05%
2002	N/A	+21.26%
2001	N/A	+5.14%
2000	N/A	+40.63%
1999	N/A	+0.87%

BBIO vs ALB Drawdown Comparison

The maximum drawdown for BBIO was -92.80%, occurring on May 11, 2022. Recovery took 1211 trading sessions.

The maximum drawdown for ALB was -83.90%, occurring on Apr 8, 2025. This drawdown has not yet recovered.

The current BBIO drawdown is -7.86%. The current ALB drawdown is -59.29%.

Rank	BBIO	ALB
#1	-92.80% Feb 8, 2021 - Dec 3, 2025	-83.90% Nov 11, 2022 - Apr 8, 2025
#2	-65.45% Dec 23, 2019 - Nov 24, 2020	-66.29% Oct 31, 2007 - Apr 29, 2010
#3	-44.53% Sep 3, 2019 - Nov 20, 2019	-63.27% Nov 8, 2017 - Nov 27, 2020
#4	-21.99% Dec 31, 2020 - Feb 8, 2021	-44.82% May 10, 2011 - Nov 27, 2013
#5	-20.25% Jan 22, 2026 - Jul 9, 2026	-41.04% Jul 14, 2014 - May 11, 2016
#6	-16.79% Nov 22, 2019 - Dec 9, 2019	-39.26% Nov 22, 2021 - Aug 15, 2022
#7	-14.67% Jul 22, 2019 - Aug 26, 2019	-30.91% Jun 10, 2002 - Jun 29, 2004
#8	-12.87% Jul 11, 2019 - Jul 22, 2019	-30.70% Dec 28, 2000 - Mar 4, 2002
#9	-7.86% Jul 9, 2026 - Jul 13, 2026	-26.73% Aug 16, 2000 - Dec 28, 2000
#10	-6.70% Dec 12, 2019 - Dec 18, 2019	-24.92% Nov 15, 1999 - Mar 20, 2000
#11	-6.15% Jan 2, 2026 - Jan 13, 2026	-24.05% Jan 19, 2021 - Jul 12, 2021
#12	-5.62% Jul 5, 2019 - Jul 11, 2019	-22.55% Sep 14, 2022 - Nov 10, 2022
#13	-5.28% Aug 27, 2019 - Sep 3, 2019	-20.14% Apr 23, 2007 - Sep 26, 2007
#14	-4.46% Dec 1, 2020 - Dec 4, 2020	-18.86% Dec 1, 2004 - Jan 3, 2006
#15	-4.45% Dec 18, 2019 - Dec 20, 2019	-15.62% Apr 29, 2010 - Sep 30, 2010